Actively Recruiting
A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis
Led by Peking University Shenzhen Hospital · Updated on 2025-06-12
140
Participants Needed
1
Research Sites
356 weeks
Total Duration
On this page
Sponsors
P
Peking University Shenzhen Hospital
Lead Sponsor
B
BGI, China
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis
CONDITIONS
Official Title
A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 55 years old with a history of sexual activity
- Diagnosed with bacterial vaginosis using Amsel criteria
- Signed informed consent to participate in the study
You will not qualify if you...
- History of systemic organic diseases or psychiatric disorders
- Currently pregnant, planning pregnancy, breastfeeding, or menstruating
- Used any antibiotics within 5 days before the study
- Long-term use of contraceptives or immunosuppressant drugs
- Known allergy to study drug ingredients or anaphylactic constitution
- No stable sexual partner before and after treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Shenzhen Hosptal
Shenzhen, Guangdong, China, 518036
Actively Recruiting
Research Team
S
Shangrong Fan, M.D.
CONTACT
Y
Yiheng Liang, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here